FDA.reportPublic FDA data

BLEPHAMIDE 10 % / 0.2 % Ophthalmic Suspension

RxCUI
1012017
RxNorm name
BLEPHAMIDE 10 % / 0.2 % Ophthalmic Suspension
Display name
BLEPHAMIDE 10 % / 0.2 % Ophthalmic Suspension
Full name
BLEPHAMIDE 10 % / 0.2 % Ophthalmic Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:02

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
69465827-dd70-483e-84c7-ced49af5d189BLEPHAMIDE 10 % / 0.2 % Ophthalmic Suspension [PSN] · prednisolone acetate 2 MG/ML / sulfacetamide sodium 100 MG/ML Ophthalmic Suspension [Blephamide] [SBD] · Blephamide (prednisolone acetate 0.2 % / sulfacetamide sodium 10 % ) Ophthalmic Suspension [SY]31BLEPHAMIDE ® (sulfacetamide sodium – prednisolone acetate ophthalmic suspension, USP) 10%/0.2%20131115